Insider Buy/Sell Ratio - USA Drug Manufacturers, CFO : 1.00 (As of 2024-04-01)

To

Historical Data

Date
Value
YOY (%)
2024-04-01
1.00
+203.03%
2024-03-01
0.29
+16.00%
2024-02-01
0.14
-17.65%
2024-01-01
0.67
+294.12%
2023-12-01
0.33
+13.79%
2023-11-01
1.00
0%
2023-10-01
1.00
+203.03%
2023-09-01
1.25
+278.79%
2023-08-01
0.40
+185.71%
2023-07-01
0.20
+42.86%
2023-06-01
0.14
0%
2023-05-01
0.40
-80.00%
2023-04-01
0.33
+135.71%
2023-03-01
0.25
+78.57%
Total 124

Basic Info

Insider Buy/Sell Ratio - USA Drug Manufacturers, CFO was 1.00 as of 2024-04-01, according to GuruFocus. Historically, Insider Buy/Sell Ratio - USA Drug Manufacturers, CFO reached a record high of 3.00 and a record low of 0.07, the median value is 0.40. Typical value range is from 0.07 to 1.07. The Year-Over-Year growth is 202.11%. GuruFocus provides the current actual value, an historical data chart and related indicators for Insider Buy/Sell Ratio - USA Drug Manufacturers, CFO - last updated on 2024-04-01.

Monthly data, but the recent month data is updated daily. Note that the monthly insider buy/sell ratio for the current month is calculated based on insider buy/sell transactions within 30 days.

Category Market Trend
Region USA
Source GuruFocus

Stats

Name Value
Last Value 1.00
Latest Period 2024-04-01
Long Term Average 0.55
Average Annualized Growth Rate 0%
Value from 1 year ago 0.33
Change from 1 year ago +203.03%
Frequency Daily
Unit

Related Indicators

Related Item
Date
Value
Unit
1-Year Growth
3-Year Growth
5-Year Growth
10-Year Growth
2024-04-01
1.00
 
+202.11%
-20.61%
+40.06%
+6.93%
2024-04-01
0.27
 
-30.70%
+10.51%
-8.01%
-2.83%
2024-04-01
0.27
 
-44.81%
+10.51%
-2.08%
-1.05%
2024-04-01
0.13
 
-40.82%
-10.27%
-9.14%
-1.42%
2024-04-01
0.20
 
-4.75%
+3.57%
-8.96%
-1.39%
2024-04-01
0.33
 
-13.12%
+20.18%
-14.90%
+0.63%
2024-04-01
0.14
 
-12.47%
-22.42%
-14.12%
+16.64%
2024-04-01
0.24
 
-11.08%
+1.43%
-16.16%
-2.52%
2024-04-01
0.19
 
-47.13%
-8.73%
-22.94%
-3.80%
2024-04-01
0.13
 
-53.47%
-28.10%
-24.48%
-12.49%
2024-04-01
0.56
 
+43.45%
+3.85%
+30.11%
+14.07%
2024-04-01
4.00
 
+59.79%
+58.67%
+51.50%
+43.72%
2024-04-01
0.08
 
+59.79%
-10.06%
-40.24%
-14.85%
2024-04-01
0.33
 
-63.92%
-21.01%
-19.57%
-10.49%
2023-02-01
1.00
 
-
-
-
+9.73%
2024-04-01
0.07
 
-22.17%
-24.07%
-21.82%
-8.48%
2024-04-01
0.17
 
+21.36%
-12.05%
-7.30%
-6.41%
2024-04-01
0.14
 
+39.87%
-17.56%
-3.74%
-
2024-04-01
0.14
 
+99.62%
+20.49%
-3.80%
-7.64%
2024-04-01
0.80
 
+368.60%
+151.77%
-4.36%
+3.63%
2024-04-01
0.11
 
+37.38%
+16.24%
-
+0.96%
2024-04-01
0.21
 
-55.22%
+71.10%
+2.02%
+13.22%
2024-04-01
0.50
 
-
+41.82%
-22.83%
+15.37%
2024-04-01
0.50
 
-36.98%
+81.04%
+30.30%
+10.64%
2024-03-01
0.25
 
-63.86%
+11.26%
-12.93%
+23.40%
2023-11-01
0.50
 
-17.95%
-17.95%
-24.20%
-5.89%
2020-05-01
1.00
 
-44.71%
-
-
-

Discussions on Insider Buy/Sell Ratio - USA Drug Manufacturers, CFO

No discussions yet.